The melanocortin 3 receptor: a novel mediator of exercise-induced inflammation reduction in postmenopausal women?
The purpose of this study was to determine whether resistance exercise training-induced reductions in inflammation are mediated via melanocortin 3 receptor expression in obese (BMI 32.7 ± 3.7) women (65.6 ± 2.8 yrs) randomized to either a control (N = 11) or resistance training group (N = 12). The resistance trained group performed resistance training 3 days/week for 12 weeks. Resting blood samples were collected before and after the training intervention in both resistance trained and control groups. Resistance training upregulated melanocortin 3 receptor mRNA by 16-fold (P = .035) and decreased monocyte count, without changing leukocyte number, body composition, or body weight. Resistance trained individuals exhibited increased sensitivity to inflammatory stimuli, whereas control individuals exhibited no change. While there was no change in whole blood tumor necrosis factor alpha mRNA between the groups, whole blood interleukin 10 mRNA was higher in the resistance trained group following the intervention period. In summary, it appears that resistance training may modulate melanocortin 3 receptor expression, providing a possible mechanism for the anti-inflammatory effects of exercise training.
Department of Kinesiology, Louisiana State University, 112 Long Fieldhouse, Baton Rouge, LA 70803, USA.
Tara M
TM
Henagan
Melody D
MD
Phillips
Dennis J
DJ
Cheek
K Michelle
KM
Kirk
James J
JJ
Barbee
Laura K
LK
Stewart
Am J Physiol Cell Physiol. 2001 Apr;280(4):C769-74
11245592
Life Sci. 2007 Jan 2;80(4):356-63
17067638
Med Sci Sports Exerc. 2007 Oct;39(10):1714-9
17909397
PPAR Res. 2007;2007:95974
17389767
Obesity (Silver Spring). 2007 Nov;15(11):2664-72
18070757
Nutrition. 1993 Sep-Oct;9(5):480-91; discussion 480, 492
8286893
J Gerontol A Biol Sci Med Sci. 2006 Apr;61(4):388-93
16611706
Int J Med Sci. 2006 Dec 18;4(1):19-27
17211497
Am J Physiol. 1997 Dec;273(6):E1203-8
9435537
Psychosom Med. 2000 Jul-Aug;62(4):591-8
10949106
J Immunol. 1999 Jun 15;162(12):7446-53
10358199
Med Sci Sports Exerc. 2010 Feb;42(2):314-25
19927028
FASEB J. 2010 Dec;24(12):4835-43
20702773
Immunol Cell Biol. 2000 Oct;78(5):545-53
11050538
Immunol Cell Biol. 2000 Oct;78(5):532-5
11050536
J Clin Invest. 1996 Sep 1;98(5):1101-6
8787671
Med Sci Sports Exerc. 1980;12(3):175-81
7402053
FASEB J. 2008 Dec;22(12):4228-38
18757499
Int J Sports Med. 2008 Feb;29(2):102-9
17990210
Ann Intern Med. 2004 Jun 15;140(12):1007-14
15197018
Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16
19682539
J Physiol. 2000 Nov 1;528(Pt 3):647-55
11060137
Brain Res. 1989 Sep 25;498(1):89-98
2551459
J Physiol. 1999 Feb 15;515 ( Pt 1):287-91
9925898
Scand J Immunol. 2005 Mar;61(3):279-84
15787746
Arch Dermatol Res. 1998 Aug;290(8):425-8
9763304
Sports Med. 2006;36(5):443-58
16646631
Coron Artery Dis. 2009 Jan;20(1):15-20
19060627
J Neurosci Res. 1994 Apr 15;37(6):675-82
7519272
J Physiol. 1998 May 1;508 ( Pt 3):949-53
9518745
Peptides. 2006 Feb;27(2):404-12
16293345
Endocrinology. 1992 Jul;131(1):518-25
1612033
Med Sci Sports Exerc. 1984 Dec;16(6):616-22
6392816
J Exp Med. 1991 Nov 1;174(5):1209-20
1940799
FASEB J. 2005 Sep;19(11):1482-91
16126916
Am J Physiol. 1999 Feb;276(2):R482-9
9950928
Endocr Rev. 2006 Dec;27(7):736-49
17077189
Pharmacol Rev. 2004 Mar;56(1):1-29
15001661
J Biol Chem. 1994 May 6;269(18):13162-6
8175743
J Leukoc Biol. 2007 Mar;81(3):584-92
17135573
Endocrinology. 2007 Dec;148(12):6186-94
17901224